Levicept Limited

8 patents currently held · Updated Nov 14, 2026

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

Mar 2033

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

No maintenance fee falls due on this company's record before Nov 14, 2027.

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 8 of 8

Patent	Title	Status	Expires	Confidence
US 10,751,389	Therapeutic use of p75NTR neurotrophin binding protein In force Ends no later than Mar 14, 2033 · From the USPTO record	In force	Ends no later than Mar 14, 2033	From the USPTO record
US 9,764,000	Therapeutic use of p75NTR neurotrophin binding protein In force Term ends Sep 24, 2033 · From the USPTO record	In force	Term ends Sep 24, 2033	From the USPTO record
US 12,201,672	Nucleic acids encoding p75NTR neurotrophin binding proteins In force Term ends Aug 18, 2034 · From the USPTO record	In force	Term ends Aug 18, 2034	From the USPTO record
US 9,873,728	p75NTR(NBP) fusion proteins and use of treating symptoms of pain In force Term ends Sep 18, 2034 · From the USPTO record	In force	Term ends Sep 18, 2034	From the USPTO record
US 10,988,526	DNA molecule encoding a p75NTR(NBP)-Fc fusion protein In force Term ends Sep 18, 2034 · From the USPTO record	In force	Term ends Sep 18, 2034	From the USPTO record
US 12,679,880	Therapeutic Use of P75NTR Neurotrophin Binding Protein In force Ends no later than Jul 31, 2035 · Low confidence	In force	Ends no later than Jul 31, 2035	Low confidence
US 10,683,339	P75NTR binding protein-Fc fusion protein and methods of treating pain In force Term ends Mar 18, 2036 · From the USPTO record	In force	Term ends Mar 18, 2036	From the USPTO record
US 11,339,202	Therapeutic Use of P75NTR Neurotrophin Binding Protein In force Ends no later than Aug 25, 2036 · Medium confidence	In force	Ends no later than Aug 25, 2036	Medium confidence

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 no status recorded

List them